Advertisement
Australia markets closed
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • AUD/USD

    0.6446
    +0.0010 (+0.15%)
     
  • ASX 200

    7,642.10
    +36.50 (+0.48%)
     
  • OIL

    82.61
    -0.08 (-0.10%)
     
  • GOLD

    2,393.90
    +5.50 (+0.23%)
     
  • Bitcoin AUD

    95,081.47
    -3,587.51 (-3.64%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

American Shared Hospital Services Announces Fourth Quarter and Year End 2022 Earnings Conference Call

American Shared Hospital Services
American Shared Hospital Services

Conference Call on Friday March 24th, 2023 at 1:00 pm ET / 10:00 am PT

SAN FRANCISCO, CA, March 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a quarterly conference call to discuss its fourth quarter and year end 2022 financial results on Friday March 24th, 2023 at 1:00 pm ET / 10:00 am PT. The fourth quarter and year end 2022 financial results press release will be issued before the market open on Friday March 24th, 2023.

Teleconference Date/Time

Friday March 24th, 2023 at 1:00 pm ET / 10:00 am PT

ADVERTISEMENT

Teleconference and Webcast Information

To participate, please call 1 (844) 413-3972 at least 10 minutes prior to the start of the call and ask to join the American Shared Hospital Services call.

A simultaneous webcast of the call may be accessed through the Company's website, www.ashs.com, or at www.streetevents.com for institutional investors.

A replay of the call will be available at 1 (877) 344-7529, access code 7388246, through March 31, 2023. The call will also be available for replay on the Company’s website, www.ashs.com, for one year.

About American Shared Hospital Services (NYSE American: AMS)

American Shared Hospital Services is a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. AMS is a world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations, and trigeminal neuralgia (facial pain). The Company also offers proton therapy, and the latest IGRT, IMRT and MR/LINAC systems. For more information, please visit: www.ashs.com.

Contacts:
American Shared Hospital Services
Ray Stachowiak
Executive Chairman
rstachowiak@ashs.com

Investor Relations
PCG Advisory
Stephanie Prince
(646) 863-6341
sprince@pcgadvisory.com